医疗用品分销商Owens & Minor推出针对糖尿病和其他慢性疾病的ByramConnect数字健康平台
)--Byram Healthcare, a leader in home-based care and part of the Owens & Minor (NYSE: OMI) family, recently launched ByramConnect
)--Byram Healthcare是家庭护理领域的领导者，也是Owens&Minor（纽约证券交易所：OMI）家族的一员，最近推出了ByramConnect
, a personalized digital health program powered by the Welldoc App
，一个由Welldoc应用程序支持的个性化数字健康计划
. Using the Welldoc App’s advanced artificial intelligence capabilities, the program analyzes member data across six dimensions of health to help optimize outcomes for people with type 1 or type 2 diabetes and associated chronic conditions such as hypertension, weight management, and cardiovascular risk, providing Byram members with actionable insights and reports that can be shared with their providers and care teams..
该计划利用Welldoc应用程序的高级人工智能功能，分析健康六个维度的成员数据，以帮助优化1型或2型糖尿病患者以及高血压、体重管理和心血管风险等相关慢性病患者的预后，为Byram成员提供可行的见解和报告，可与他们的提供者和护理团队分享。。
“Chronic health conditions like diabetes are complex and can have long-term health implications that require multiple supportive interventions over the course of a member’s care journey,” said Perry Bernocchi, EVP and CEO, Patient Direct, Owens & Minor. “We’re proud to offer Byram members a clinically validated platform designed to help them achieve concrete goals, such as weight management and improved control over their diabetes, in addition to longer-lasting behavior changes that help support a lifetime of better overall health.”.
Owens＆Minor公司执行副总裁兼首席执行官Perry Bernocchi说：“糖尿病等慢性疾病很复杂，可能会对健康产生长期影响，需要在成员的护理过程中进行多种支持性干预。”。“我们很荣幸为Byram会员提供一个经过临床验证的平台，旨在帮助他们实现具体目标，例如体重管理和改善对糖尿病的控制，以及更持久的行为改变，以帮助他们实现更好的整体健康。”。
ByramConnect powered by the Welldoc App is a U.S. Food and Drug Administration (FDA)-cleared class II software as a medical device (SaMD) intended for use by healthcare providers and adult patients with type 1 or type 2 diabetes*. In clinical studies, patients using the app saw improvements in several important measures related to their condition, including reduced (A1C), lower blood pressure and lower body weight..
由Welldoc应用程序驱动的ByramConnect是美国食品和药物管理局（FDA）批准的II类医疗器械软件（SaMD），旨在供医疗保健提供者和1型或2型糖尿病成年患者使用*。在临床研究中，使用该应用程序的患者在与病情相关的几个重要指标上都有所改善，包括降低（A1C），降低血压和降低体重。。
The ByramConnect platform offers Byram diabetes customers access to the Welldoc
ByramConnect平台为Byram糖尿病客户提供了对Welldoc的访问
App, which provides their care teams a holistic view of their condition by combining patient-tracked health data and connected sources such as fitness trackers, blood glucose meters, continuous glucose monitors (CGMs), blood pressure monitors, scales, heart rate monitors and medical labs and pharmacies..
该应用程序通过结合患者跟踪的健康数据和连接的来源，如健身跟踪器、血糖仪、连续血糖监测仪（CGM）、血压监测仪、量表、心率监测仪以及医疗实验室和药房，为护理团队提供其状况的整体视图。。
Additional ByramConnect powered by the Welldoc
Welldoc提供的附加ByramConnect
App benefits include:
应用程序的优点包括：
: personalized, AI-driven digital coaching providing real-time feedback and coaching based on a patient’s unique data and trends
：个性化、人工智能驱动的数字指导，根据患者的独特数据和趋势提供实时反馈和指导
Diet and nutrition support:
饮食和营养支持：
tracking, insights and guidance to help promote healthy eating habits, including meal planning and restaurant recommendations based on dietary requirements
跟踪、洞察和指导，以帮助促进健康的饮食习惯，包括根据饮食要求制定饮食计划和餐厅建议
GLP-1 medication support
GLP-1药物支持
: support to help patients manage medications, monitor potential side-effects and track adherence over time
：支持帮助患者管理药物，监测潜在的副作用，并随着时间的推移跟踪依从性
Reporting & insights:
报告和见解：
health reports with actionable insights based on the patient’s unique data, patterns and trends that patients can share with their provider and care team
基于患者独特的数据、模式和趋势的健康报告，提供可行的见解，患者可以与他们的提供者和护理团队分享
guidance and reinforcement to help members manage overall wellbeing, including mood, sleep and anxiety
指导和强化，帮助会员管理整体健康，包括情绪、睡眠和焦虑
. The other Welldoc
.另一个Welldoc
App products are non-FDA-cleared and intended to promote general wellness and education/self-management of various chronic disease states.
App产品未经FDA批准，旨在促进各种慢性病状态的一般健康和教育/自我管理。
ByramConnect powered by the Welldoc
由Welldoc提供动力的ByramConnect
App can be used on any device and is available now as an included service exclusively for Byram diabetes customers at no additional charge. Byram customers will receive an invitation via email within the next couple of weeks with an exclusive access code allowing them to download the app from the Apple or Google Play App stores.
该应用程序可以在任何设备上使用，现在作为专为Byram diabetes客户提供的包含服务免费提供。Byram客户将在未来几周内通过电子邮件收到邀请，并提供专有访问代码，允许他们从苹果或谷歌Play应用程序商店下载该应用程序。
About Owens & Minor
关于Owens&Minor
Owens & Minor, Inc. (
欧文斯美诺公司(
) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. For over 100 years, Owens & Minor and its affiliated brands, Apria
)是一家财富500强全球医疗保健解决方案公司，提供从医院到家庭的基本产品和服务。100多年来，Owens&Minor及其附属品牌Apria
, have helped to make each day better for the patients, providers and communities we serve. Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere,
，有助于使我们服务的患者，提供者和社区的每一天都变得更好。在全球20000多名队友的支持下，Owens&Minor在幕后提供了舒适和自信，因此医疗保健始终处于领先地位。Owens&Minor的存在是因为每一天，每一个地方，
Byram Healthcare (“Byram” or “Byram Healthcare Centers, Inc.”), part of the Owens & Minor family, delivers the products, services and support patients need to help improve health outcomes and affordability of care in the home. Along with Apria, Byram Healthcare makes up the Owens & Minor Patient Direct business segment, which serves nearly three million patients each year and offers one of the broadest portfolios of products for chronic and acute conditions including diabetes, wound care, sleep health, respiratory care, urology and ostomy care.
Byram Healthcare（“Byram”或“Byram Healthcare Centers，Inc.”）是Owens&Minor家族的一部分，提供患者所需的产品、服务和支持，以帮助改善健康状况和家庭护理的负担能力。与Apria一起，Byram Healthcare构成了Owens&Minor Patient Direct业务部门，该部门每年为近300万患者提供服务，并为慢性和急性疾病提供最广泛的产品组合之一，包括糖尿病、伤口护理、睡眠保健、呼吸保健、泌尿科和造口保健。
Welldoc, a digital health leader revolutionizing cardiometabolic care, is integrating personalized, real-time and actionable insights into the daily lives of individuals living with cardiometabolic conditions, enabling improved health and outcomes. Welldoc’s comprehensive digital health platform provides AI-powered digital coaching across pre-diabetes, diabetes, hypertension, heart failure and weight and obesity management, with integrated mental wellbeing and sleep support.
Welldoc是一家革新心脏代谢护理的数字健康领导者，正在将个性化，实时和可行的见解整合到患有心脏代谢疾病的个体的日常生活中，从而改善健康和预后。Welldoc的综合数字健康平台为糖尿病前期、糖尿病、高血压、心力衰竭以及体重和肥胖管理提供人工智能支持的数字指导，并提供综合的心理健康和睡眠支持。
App is an FDA-cleared digital health solution that guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their care while enhancing connections to their healthcare team. For more information, visit
App是FDA批准的数字健康解决方案，通过使个人能够自我管理自己的护理，同时增强与医疗团队的联系，指导个人度过糖尿病的复杂旅程。有关更多信息，请访问
相关知识
泰康发布数字化糖尿病慢病管理产品
预防糖尿病和其他慢性疾病的健康养生指南
Welldoc扩展慢性病数字健康平台，将体重管理纳入其中
泰康发布数字化糖尿病慢病管理产品 创新糖尿病管理新模式
平安健康数字化糖尿病管理研究报告重磅发布
探讨在线医疗健康管理平台对慢性病管理的贡献
大数据与医疗健康：个性化治疗与疾病预测
【疾病报告】糖尿病后治疗时代，是GLP
【海豚健康云】智能数字化慢病管理平台
从产品外销到远程健康监测，物联网医疗厂商角逐慢病管理市场
网址: 医疗用品分销商Owens & Minor推出针对糖尿病和其他慢性疾病的ByramConnect数字健康平台 https://m.trfsz.com/newsview1560835.html
